EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Exploring the therapeutic potential of modulating nonsense-mediated mRNA decay

Mary McMahon, Lynne E Maquat

RNA · 2025

DOI: 10.1261/rna.080334.124 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RNA, 2025. Verfasst von Mary McMahon und 1 weiteren Autor:innen. Beteiligte Einrichtung: ReviR Therapeutics, Brisbane, California 94005, USA mary.mcmahon@revirtx.com lynne_maquat@urmc.rochester.edu. Hauptthemen laut MEDLINE: Nonsense Mediated mRNA Decay, RNA, Messenger. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Discovered more than four decades ago, nonsense-mediated mRNA decay (NMD) plays a fundamental role in the regulation of gene expression and is a major contributor to numerous diseases. With advanced technologies, several novel approaches aim to directly circumvent the effects of disease-causing frameshift and nonsense mutations. Additional therapeutics aim to globally dampen the NMD pathway in diseases associated with pathway hyperactivation, one example being Fragile X syndrome. In other cases, therapeutics have been designed to hijack or inhibit the cellular NMD machinery to either activate or obviate transcript-specific NMD by modulating pre-mRNA splicing. Here, we discuss promising approaches employed to regulate NMD for therapeutic purposes and highlight potential challenges in future clinical development. We are optimistic that the future of developing target-specific and global modulators of NMD (inhibitors as well as activators) is bright and will revolutionize the treatment of many genetic disorders, especially those with high unmet medical need.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nonsense Mediated mRNA DecayRNA, MessengerHumansRNA SplicingCodon, NonsenseAnimalsFragile X SyndromeGene Expression Regulation

Stichwörter der Autor:innen

NMDgene therapypre-mRNA splicingsite-directed RNA editingsmall-molecule modulators of splicingsmall-molecule modulators of translation termination

Substanzen

RNA, MessengerCodon, Nonsense

Autor:innen und Institutionen

  • ReviR Therapeutics, Brisbane, California 94005, USA mary.mcmahon@revirtx.com lynne_maquat@urmc.rochester.edu.
  • Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, New York 14642, USA mary.mcmahon@revirtx.com lynne_maquat@urmc.rochester.edu.
  • Center for RNA Biology, University of Rochester, Rochester, New York 14642, USA.

Förderung

  • NIGMS NIH HHS

Zitieren

APA

McMahon, M., & Maquat, L. E. (2025). Exploring the therapeutic potential of modulating nonsense-mediated mRNA decay. RNA. https://doi.org/10.1261/rna.080334.124

Vancouver

McMahon M, Maquat LE. Exploring the therapeutic potential of modulating nonsense-mediated mRNA decay. RNA. 2025. doi:10.1261/rna.080334.124

BibTeX
@article{McMahon2025,
  author = {McMahon, Mary and Maquat, Lynne E},
  title = {Exploring the therapeutic potential of modulating nonsense-mediated mRNA decay},
  journal = {RNA},
  year = {2025},
  doi = {10.1261/rna.080334.124}
}
Kostenlos starten →